From: Meghan on
Looking for Options for someone between 10 and 20 years of age
recently diagnosed with Type 1 Diabetes?

If you or a family member has been diagnosed with Type 1 Diabetes
within the last three months, then this clinical trial may be of
interest to you.

The DiaPrevent research study aims to find out if the investigational
study vaccine, named Diamyd, may preserve the body's ability to
produce insulin in children and young adults with Type 1 Diabetes. As
in other research studies, the study vaccine will be compared to a
placebo (shots without the active drug). Two out of three
participants will receive active study vaccine and one out of three
will receive placebo. There is a 66% percent chance you will receive
the investigational study vaccine Diamyd if you choose to participate
in the study.

This study might be appropriate if you or a family member:

• Are between 10 and 20 years of age
• Have been diagnosed with Type 1 Diabetes within the past 3 months
• Meet other study entry criteria

If you qualify for this study, you will receive one shot at 4
different occasions and your diabetes will be monitored for a period
of 2.5 years. All study-related procedures, laboratory tests,
examinations and the study drug will be provided at no cost. The
DiaPrevent research study will include 320 participants at 30 to 50
sites across the United States. We hope that the DiaPrevent study
will lead to advancements in the treatment of Type 1 Diabetes.

For more information or to determine if you qualify for this research
opportunity, please call toll-free 1-877-784-5302 or visit